Resources from the same session
Introduction and scientific background
Presenter: Helen Gogas
Session: Why neoadjuvant immunotherapy is the future for melanoma
Resources:
Slides
Webcast
Summary of clinical trials so far
Presenter: Paolo Ascierto
Session: Why neoadjuvant immunotherapy is the future for melanoma
Resources:
Slides
Webcast
Personalised immunotherapy approach and future
Presenter: Christian Blank
Session: Why neoadjuvant immunotherapy is the future for melanoma
Resources:
Slides
Webcast
Which patients need surgery?
Presenter: Alexander van Akkooi
Session: Why neoadjuvant immunotherapy is the future for melanoma
Resources:
Slides
Webcast
Q&A and discussion
Session: Why neoadjuvant immunotherapy is the future for melanoma
Resources:
Webcast
Conclusions and perspectives
Presenter: Christian Blank
Session: Why neoadjuvant immunotherapy is the future for melanoma
Resources:
Slides
Webcast